These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1927837)
21. Carisoprodol withdrawal syndrome misdiagnosed as a psychotic disorder. Reeves RR; Ladner ME Ann Clin Psychiatry; 2008; 20(3):173-4. PubMed ID: 18633744 [No Abstract] [Full Text] [Related]
22. Gamma-hydroxybutyrate (GHB): a newer drug of abuse. O'Connell T; Kaye L; Plosay JJ Am Fam Physician; 2000 Dec; 62(11):2478-83. PubMed ID: 11130233 [TBL] [Abstract][Full Text] [Related]
23. Carisoprodol: a drug of continuing abuse. Reeves RR; Pinkofsky HB; Carter OS J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144 [TBL] [Abstract][Full Text] [Related]
24. Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers. Zacny JP; Paice JA; Coalson DW Drug Alcohol Depend; 2012 Jan; 120(1-3):229-32. PubMed ID: 21840651 [TBL] [Abstract][Full Text] [Related]
25. Carisoprodol dependence: a case report. Morse RM; Chua L Am J Drug Alcohol Abuse; 1978; 5(4):527-30. PubMed ID: 755391 [TBL] [Abstract][Full Text] [Related]
26. Trends in carisoprodol abuse and misuse after regulatory scheduling: a retrospective review of California poison control calls from 2008 to 2015. Sun C; Hollenbach KA; Cantrell FL Clin Toxicol (Phila); 2018 Jul; 56(7):653-655. PubMed ID: 29228807 [TBL] [Abstract][Full Text] [Related]
33. National drug control policy and prescription drug abuse: facts and fallacies. Manchikanti L Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776 [TBL] [Abstract][Full Text] [Related]
34. Prescription drug misuse/abuse in the elderly. Culberson JW; Ziska M Geriatrics; 2008 Sep; 63(9):22-31. PubMed ID: 18763848 [TBL] [Abstract][Full Text] [Related]
35. [Carisoprodol--one more time]. Reiestad F; Fagerlund B Tidsskr Nor Laegeforen; 2002 Jan; 122(3):327. PubMed ID: 11894608 [No Abstract] [Full Text] [Related]
36. [Acting out and psychoactive substances: alcohol, drugs, illicit substances]. Gillet C; Polard E; Mauduit N; Allain H Encephale; 2001; 27(4):351-9. PubMed ID: 11686057 [TBL] [Abstract][Full Text] [Related]
37. Is it time for carisoprodol to become a controlled substance at the federal level? Reeves RR; Burke RS South Med J; 2008 Feb; 101(2):127-8. PubMed ID: 18364610 [No Abstract] [Full Text] [Related]
38. Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc. NIDA Res Monogr; 1984; 52():1-153. PubMed ID: 6148699 [No Abstract] [Full Text] [Related]
39. [Is carisoprodol justified as a muscle relaxant?]. Reiestad F; Fagerlund B Tidsskr Nor Laegeforen; 2000 Jun; 120(17):2041-2. PubMed ID: 11008544 [No Abstract] [Full Text] [Related]
40. Occupation and the prevalence of major depression, alcohol, and drug abuse in the United States. Roberts RE; Lee ES Environ Res; 1993 May; 61(2):266-78. PubMed ID: 8495668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]